ANALYSIS: Healthcare IT lifts September’s VC takings
This article was originally published in Clinica
September brought a new low in the number of medtech venture financing deals, with only 16 transactions of $1m or over recorded. This is the smallest monthly deal volume this year to date, and is a significant 20% drop from August, which only had 20 transactions (www.clinica.co.uk, 10 September 2013). However, dollar-wise, September beat August by raking in over $209m, not including the one transaction that did not disclose the sum raised. This was down to the absence of big-buck deals in August, where the total VC dollars raised slipped just past $179m, while September had a whopping $70m Series D transaction to hike up the total deal value that month (see Fig 1). Excluding this transaction, the total deal value for September would have been well below that of August at $139m, as there was even a significant decrease in the number of small, below-$10m financings.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.